Literature DB >> 19148477

Short hairpin RNA (shRNA) constructs targeting high mobility group box-1 (HMGB1) expression leads to inhibition of prostate cancer cell survival and apoptosis.

Munirathinam Gnanasekar1, Sivasakthivel Thirugnanam, Kalyanasundaram Ramaswamy.   

Abstract

High mobility group box protein 1 (HMGB1), transcriptional activity regulatory protein is associated with most cancers including prostate cancer. To investigate the effects of down-regulation of HMGB1 expression, we have transfected LNCaP cells with four short hairpin RNA (shRNA) targeting HMGB1 plasmid vectors. Transfection with the four shRNAs efficiently and specifically reduced the HMGB1 expression in LNCaP cells. The gene silencing effects on HMGB1 expression were subsequently confirmed by RT-PCR and immunoblotting analyses. Down-regulation of HMGB1 expression resulted in the inhibition of cell growth in LNCaP prostate cancer cells and the decreased cell number was due to transfected cells undergoing apoptosis via caspase-3-dependent pathways. These findings suggest that HMGB1 is critical for the survival of prostate cancer cells and targeted knockdown of HMGB1 mRNA can be used as a strategy to kill prostate cancer cells. Our findings may have some potential therapeutic relevance for treating prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19148477

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  28 in total

1.  The combination of a nuclear HMGB1-positive and HMGB2-negative expression is potentially associated with a shortened survival in patients with pancreatic ductal adenocarcinoma.

Authors:  Toru Takeda; Hiroto Izumi; Shohei Kitada; Hidetaka Uramoto; Takashi Tasaki; Li Zhi; Xin Guo; Yuichiro Kawatsu; Tomoko Kimura; Seichi Horie; Atsunori Nabeshima; Hirotsugu Noguchi; Ke-Yong Wang; Yasuyuki Sasaguri; Kimitoshi Kohno; Sohsuke Yamada
Journal:  Tumour Biol       Date:  2014-07-26

2.  Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis.

Authors:  Ruiguang Zhang; Yan Li; Zhongliang Wang; Lingjuan Chen; Xiaorong Dong; Xiu Nie
Journal:  Tumour Biol       Date:  2015-06-04

3.  Knockdown of HMGB1 in tumor cells attenuates their ability to induce regulatory T cells and uncovers naturally acquired CD8 T cell-dependent antitumor immunity.

Authors:  Zuqiang Liu; Louis D Falo; Zhaoyang You
Journal:  J Immunol       Date:  2011-06-03       Impact factor: 5.422

Review 4.  HMGB1 in hormone-related cancer: a potential therapeutic target.

Authors:  Madhuwanti Srinivasan; Souresh Banerjee; Allison Palmer; Guoxing Zheng; Aoshuang Chen; Maarten C Bosland; André Kajdacsy-Balla; Ramaswamy Kalyanasundaram; Gnanasekar Munirathinam
Journal:  Horm Cancer       Date:  2014-04-10       Impact factor: 3.869

5.  The expression of high mobility group box 1 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.

Authors:  Chen Chuangui; Tang Peng; Yu Zhentao
Journal:  Pathol Oncol Res       Date:  2012-04-29       Impact factor: 3.201

Review 6.  High-mobility group box 1 and cancer.

Authors:  Daolin Tang; Rui Kang; Herbert J Zeh; Michael T Lotze
Journal:  Biochim Biophys Acta       Date:  2010 Jan-Feb

7.  Downregulation of HMGB1 by miR-34a is sufficient to suppress proliferation, migration and invasion of human cervical and colorectal cancer cells.

Authors:  Karthik Subramanian Chandrasekaran; Anusha Sathyanarayanan; Devarajan Karunagaran
Journal:  Tumour Biol       Date:  2016-07-25

8.  Co-expression of RAGE and HMGB1 is associated with cancer progression and poor patient outcome of prostate cancer.

Authors:  Chu-Biao Zhao; Ji-Ming Bao; Yong-Jie Lu; Tong Zhao; Xin-Hua Zhou; Da-Yong Zheng; Shan-Chao Zhao
Journal:  Am J Cancer Res       Date:  2014-07-16       Impact factor: 6.166

Review 9.  Pivotal role of high-mobility group box 1 (HMGB1) signaling pathways in glioma development and progression.

Authors:  Efthalia Angelopoulou; Christina Piperi; Christos Adamopoulos; Athanasios G Papavassiliou
Journal:  J Mol Med (Berl)       Date:  2016-06-04       Impact factor: 4.599

10.  HMGB1 promotes cellular proliferation and invasion, suppresses cellular apoptosis in osteosarcoma.

Authors:  Qingbing Meng; Jie Zhao; Hongbing Liu; Guoyou Zhou; Wensheng Zhang; Xingli Xu; Minqian Zheng
Journal:  Tumour Biol       Date:  2014-08-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.